How Nurses Can Support Physicians in Identifying Colorectal Cancer Risk

Video

Ascertaining family history and promoting screening are key.

Nurses can support providers in identifying patients’ colorectal cancer risk by enabling them with the tools and information needed to assess it.

“Colorectal cancer is the most preventable solid tumor on the planet,” says Thomas Weber, MD, FACS, founder and president of the Colon Cancer Foundation.

In this video, Weber explains how nurses can focus on ascertaining patients’ family history and ensuring that patients get their colonoscopies when they are due.

Related Videos
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
Inconsistent Symptom Clusters Warrant Routine Assessments in Older Patients With Cancer

Inconsistent Symptom Clusters Warrant Routine Assessments in Older Patients With Cancer

April 25th 2024
Article

Older patients with cancer demonstrated a moderate to high symptom burden, leading to the need for routine symptom assessments and tailored management interventions.

The Vitals

ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

October 31st 2023
Podcast

Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.

Survival Benefit Persists at 3 Years With Durvalumab Plus Chemo in Advanced Biliary Tract Cancer

Survival Benefit Persists at 3 Years With Durvalumab Plus Chemo in Advanced Biliary Tract Cancer

April 16th 2024
Article

Superior 3-year survival outcomes were observed with durvalumab plus chemotherapy compared with chemotherapy alone in patients with advanced biliary tract cancer.

The Vitals

Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

March 1st 2023
Podcast

In this episode of "The Vitals," Terri Pollack, DNP, APRN, FNP-C, PMHNP-BC, underscores potentially practice-changing data which were presented during the 2023 GI Cancers Symposium.

FDA Approves Fluorouracil Safety Label Update Regarding DPD Deficiency Use

FDA Approves Fluorouracil Safety Label Update Regarding DPD Deficiency Use

March 22nd 2024
Article

The safety label for fluorouracil products will now include information about the agent’s use in patients with dihydropyrimidine dehydrogenase deficiency.

Aiming to Improve QOL With Radiation in Rectal Cancer

Aiming to Improve QOL With Radiation in Rectal Cancer

March 21st 2024
Article

An expert discusses how radiation may improve quality of life in patients with rectal cancer, in addition to when radiation or surgery could be omitted.

© 2024 MJH Life Sciences

All rights reserved.